A detailed history of Cetera Investment Advisers transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 7,626 shares of TMDX stock, worth $477,768. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,626
Previous 8,705 12.4%
Holding current value
$477,768
Previous $1.31 Million 8.7%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$135.68 - $176.11 $146,398 - $190,022
-1,079 Reduced 12.4%
7,626 $1.2 Million
Q2 2024

Aug 22, 2024

SELL
$72.62 - $150.62 $174,360 - $361,638
-2,401 Reduced 21.62%
8,705 $1.31 Million
Q1 2024

May 24, 2024

BUY
$70.86 - $89.93 $520,183 - $660,176
7,341 Added 194.98%
11,106 $821,000
Q1 2024

May 14, 2024

SELL
$70.86 - $89.93 $335,734 - $426,088
-4,738 Reduced 55.72%
3,765 $278,000
Q4 2023

Feb 13, 2024

BUY
$36.74 - $81.08 $33,727 - $74,431
918 Added 12.1%
8,503 $671,000
Q3 2023

Nov 14, 2023

BUY
$53.47 - $96.07 $12,565 - $22,576
235 Added 3.2%
7,585 $415,000
Q2 2023

Aug 09, 2023

BUY
$66.23 - $88.73 $12,981 - $17,391
196 Added 2.74%
7,350 $617,000
Q1 2023

May 15, 2023

SELL
$53.63 - $82.33 $101,628 - $156,015
-1,895 Reduced 20.94%
7,154 $541,000
Q4 2022

Feb 14, 2023

BUY
$39.08 - $64.29 $64,794 - $106,592
1,658 Added 22.43%
9,049 $558,000
Q3 2022

Nov 10, 2022

SELL
$31.56 - $55.75 $86,569 - $152,922
-2,743 Reduced 27.07%
7,391 $309,000
Q2 2022

Aug 11, 2022

BUY
$20.56 - $32.15 $534 - $835
26 Added 0.26%
10,134 $319,000
Q1 2022

May 13, 2022

SELL
$12.58 - $26.94 $16,253 - $34,806
-1,292 Reduced 11.33%
10,108 $272,000
Q4 2021

Feb 14, 2022

BUY
$19.16 - $32.68 $13,871 - $23,660
724 Added 6.78%
11,400 $218,000
Q3 2021

Nov 16, 2021

BUY
$25.92 - $34.51 $7,439 - $9,904
287 Added 2.76%
10,676 $353,000
Q2 2021

Aug 13, 2021

BUY
$21.63 - $40.07 $96,945 - $179,593
4,482 Added 75.88%
10,389 $345,000
Q1 2021

May 17, 2021

BUY
$17.75 - $47.82 $104,849 - $282,472
5,907 New
5,907 $245,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.99B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.